expansion – Page 5

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

11 months ago talkbio0Tagged Administration occupational activities, ambulatory care services, Artificial Intelligence, deal activity, digital health, expansion, Gene Modification, Health care facility, Pharmaceutical Services, regulatory environment, Transplant Registry Unified Management Program

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration

AstraZeneca Invests $570M in Canadian Expansion, Creating 700 New Jobs

11 months ago talkbio0Tagged AstraZeneca, Canadian, Clinical Trials, Drug Industry, expansion, Investments, R&D

AstraZeneca, Canadian expansion, $570M investment, 700 new jobs, life sciences, R&D, clinical trials, pharmaceutical industry

GSK’s Strategic Approach to Deal-Making and Expansion Beyond Obesity with GLP-1s

11 months ago talkbio0Tagged deal-making, expansion, GLP-1s, Obesity, pharmaceutical innovation, R&D strategy, SmithKline Beecham, strategic

GSK, GLP-1s, Obesity, Deal-making, Strategic expansion, Pharmaceutical innovation, R&D strategy

Samsung Biologics Embarks on New Phase of Growth with Bio Campus II and ADC Services

11 months ago talkbio0Tagged Antibody-Drug Conjugates, Bio Campus II, Biological Factors, Capacity, CDMO, Contract agreement, development aspects, digital transformation, expansion, Manufacturing Organization, Plants, Samsung, Services

Samsung Biologics, Bio Campus II, Plant 5, antibody-drug conjugate (ADC) services, capacity expansion, digital transformation, contract development and manufacturing organization (CDMO)

Lonza Expands Gelatin Capsule Production in India and China Amid Plans to Exit Capsules Business

12 months ago talkbio0Tagged capsule (pharmacologic), China, Exit Strategy, expansion, gelatin, India, Lonza

Lonza, Capsules & Health Ingredients, Gelatin Capsules, India, China, Expansion, Exit Strategy

Regeneron and Bayer Achieve Phase III Success with High-Dose Eylea for Retinal Vein Occlusion, Paving Way for Label Expansion

12 months ago talkbio0Tagged Bayer, Biosimilars, competition, expansion, Eylea HD, Macular retinal edema, Phase 3 Clinical Trials, Regeneron, Retinal Vein Occlusion

Regeneron, Bayer, Eylea HD, Retinal Vein Occlusion (RVO), Macular Edema, Phase III Trial, Label Expansion, Biosimilar Competition

Eli Lilly Invests $3 Billion in Wisconsin Manufacturing Expansion to Meet Growing Demand for Diabetes and Obesity Medicines

1 year ago talkbio0Tagged Diabetes, Eli, Eli Lilly, expansion, Investments, Manufacturing, Obesity, Surgical construction, Wisconsin

Eli Lilly, Wisconsin, manufacturing expansion, diabetes, obesity, pharmaceuticals, investment, job creation

Amgen Expands in North Carolina with $1 Billion Biomanufacturing Facility

1 year ago talkbio0Tagged amgen, biomanufacturing, Drug Industry, expansion, Facility (object), North Carolina

Amgen, North Carolina, biomanufacturing, facility expansion, pharmaceutical industry

Philips and AWS Strengthen Strategic AI Partnership, Expanding Cloud-Enabled Diagnostics to Europe

1 year ago talkbio0Tagged Alagille Syndrome, Diagnostics, European (ethnic group), expansion, Generative AI, healthcare innovation, Integrated Diagnostics Portfolio, Philips, Strategic AI Collaboration

Philips, AWS, Strategic AI Collaboration, Cloud-Enabled Diagnostics, European Expansion, Healthcare Innovation, Integrated Diagnostics Portfolio, Generative AI Applications

Incyte Unveils Promising Monjuvi Data at ASH24, Paving Way for FDA Label Expansion in Follicular Lymphoma

1 year ago talkbio0Tagged ASH24, expansion, Incyte, Lymphoma, Follicular, Monjuvi, Phase 3 trial, United States Food and Drug Administration

Incyte, Monjuvi, ASH24, Follicular Lymphoma, Label Expansion, FDA, Phase 3 Trial